{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:18:54Z","timestamp":1789924734470,"version":"4.0.1"},"reference-count":166,"publisher":"Elsevier BV","issue":"9","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.autrev.2013.03.010","type":"journal-article","created":{"date-parts":[[2013,3,25]],"date-time":"2013-03-25T11:12:53Z","timestamp":1364209973000},"page":"863-874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Etiology of myasthenia gravis: Innate immunity signature in pathological thymus"],"prefix":"10.1016","volume":"12","author":[{"given":"Paola","family":"Cavalcante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Cufi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Berrih-Aknin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozen","family":"Le Panse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2013.03.010_bb0005","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"2","author":"Vincent","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0010","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2013.03.010_bb0015","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archneurol.2012.437","article-title":"Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis","volume":"69","author":"Jacob","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0020","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2013.03.010_bb0025","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2013.03.010_bb0030","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1212\/01.WNL.0000065882.63904.53","article-title":"Clinical aspects of MuSK antibody positive seronegative MG","volume":"60","author":"Sanders","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.010_bb0035","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0040","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.autrev.2013.03.004","article-title":"Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase","volume":"12","author":"Evoli","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0045","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.autrev.2013.03.005","article-title":"Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis","volume":"12","author":"Mori","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0050","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.autrev.2013.03.002","article-title":"Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens","volume":"12","author":"Zisimopoulou","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0055","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0060","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0065","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0070","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1196\/annals.1254.054","article-title":"Myasthenia gravis (MG): epidemiological data and prognostic factors","volume":"998","author":"Mantegazza","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.03.010_bb0075","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1212\/WNL.0b013e3181ad53c2","article-title":"Seropositive myasthenia gravis: a nationwide epidemiologic study","volume":"73","author":"Heldal","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.010_bb0080","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1212\/01.WNL.0000050461.05432.C5","article-title":"Myasthenia gravis: a higher than expected incidence in the elderly","volume":"60","author":"Aragones","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.010_bb0085","doi-asserted-by":"crossref","first-page":"A383","DOI":"10.1016\/j.autrev.2009.11.011","article-title":"Geoepidemiology of myasthenia gravis","volume":"9","author":"Meyer","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0090","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM198209233071301","article-title":"Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis","volume":"307","author":"Drachman","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2013.03.010_bb0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2004-829589","article-title":"Seronegative myasthenia gravis","volume":"24","author":"Vincent","year":"2004","journal-title":"Semin Neurol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0100","series-title":"Anderson's Pathology","first-page":"1218","article-title":"Thymus","author":"M\u00fcller-Hermelink","year":"1996"},{"key":"10.1016\/j.autrev.2013.03.010_bb0105","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.autrev.2013.03.011","article-title":"Ectopic germinal centers, BAFF and anti-B cell therapy in myasthenia gravis","volume":"12","author":"Berrih-Aknin","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0110","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.autrev.2013.03.010_bb0115","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.autrev.2013.03.006","article-title":"Novel future therapeutic options in Myasthenia Gravis","volume":"12","author":"Dalakas","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1212\/WNL.36.1.78","article-title":"Myasthenia gravis in identical twins","volume":"36","author":"Murphy","year":"1986","journal-title":"Neurology"},{"issue":"Suppl.","key":"10.1016\/j.autrev.2013.03.010_bb0125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaut.2005.09.010","article-title":"Genetics of autoimmune myasthenia gravis: the multifaceted contribution of the HLA complex","volume":"25","author":"Vandiedonck","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2013.03.010_bb0130","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF00179791","article-title":"An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes","volume":"35","author":"Degli-Esposti","year":"1992","journal-title":"Immunogenetics"},{"key":"10.1016\/j.autrev.2013.03.010_bb0135","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.autrev.2011.04.021","article-title":"An overview on the genetic of rheumatoid arthritis: a never-ending story","volume":"10","author":"Perricone","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0140","doi-asserted-by":"crossref","first-page":"A277","DOI":"10.1016\/j.autrev.2009.12.008","article-title":"The geoepidemiology of systemic lupus erythematosus","volume":"9","author":"Borchers","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0145","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-0404.1995.tb00432.x","article-title":"Associated autoimmune diseases in myasthenia gravis. A population-based study","volume":"91","author":"Christensen","year":"1995","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.autrev.2013.03.010_bb0150","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1749-6632.1998.tb10946.x","article-title":"Identification of a novel HLA class II association with DQB1*0502 in an Italian myasthenic population","volume":"841","author":"Baggi","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.03.010_bb0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1744-313X.2010.00979.x","article-title":"Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States","volume":"38","author":"Deitiker","year":"2011","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.autrev.2013.03.010_bb0160","first-page":"217","article-title":"Modification of cytokine patterns in subjects bearing the HLA-B8, DR3 phenotype: implications for autoimmunity","volume":"3","author":"Lio","year":"1997","journal-title":"Cytokines Cell Mol Ther"},{"key":"10.1016\/j.autrev.2013.03.010_bb0165","doi-asserted-by":"crossref","first-page":"e36603","DOI":"10.1371\/journal.pone.0036603","article-title":"Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population","volume":"7","author":"Maniaol","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2013.03.010_bb0170","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1212\/01.wnl.0000218159.79769.5c","article-title":"Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5","volume":"66","author":"Niks","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.010_bb0175","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1212\/01.wnl.0000339103.08830.86","article-title":"HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5","volume":"72","author":"Bartoccioni","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.010_bb0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0165-5728(93)90021-P","article-title":"Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis","volume":"47","author":"Vieira","year":"1993","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0185","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jneuroim.2009.02.004","article-title":"Association of HLA-A in autoimmune myasthenia gravis with thymoma","volume":"210","author":"Vandiedonck","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2011.08.023","article-title":"The association of HLA-DQA1*0401 and DQB1*0604 with thymomatous myasthenia gravis in northern Chinese patients","volume":"312","author":"Yang","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2013.03.010_bb0195","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archneur.56.4.457","article-title":"TNFA and TNFB polymorphisms in myasthenia gravis","volume":"56","author":"Skeie","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0200","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0165-5728(98)00253-7","article-title":"Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis","volume":"94","author":"Huang","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0205","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/intimm\/12.10.1381","article-title":"Tumor necrosis factor receptor-1 is critically involved in the development of experimental autoimmune myasthenia gravis","volume":"12","author":"Wang","year":"2000","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0210","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2796.2007.01879.x","article-title":"Two SNPs in the promoter region of the CTLA-4 gene affect binding of transcription factors and are associated with human myasthenia gravis","volume":"263","author":"Wang","year":"2008","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2013.03.010_bb0215","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.humimm.2007.02.003","article-title":"Polymorphisms of interferon-gamma, interleukin-10, and interleukin-12 genes in myasthenia gravis","volume":"68","author":"Yilmaz","year":"2007","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0220","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1016\/j.febslet.2011.04.032","article-title":"Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?","volume":"585","author":"Burn","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1016\/j.autrev.2013.03.010_bb0225","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1405.027","article-title":"Genetic factors in autoimmune myasthenia gravis","volume":"1132","author":"Giraud","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.03.010_bb0230","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.smim.2006.03.009","article-title":"PTPN22: setting thresholds for autoimmunity","volume":"18","author":"Gregersen","year":"2006","journal-title":"Semin Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0235","article-title":"The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity","author":"Gianchecchi","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0240","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1172\/JCI45790","article-title":"The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans","volume":"121","author":"Menard","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2013.03.010_bb0245","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/ng.904","article-title":"The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp\/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness","volume":"43","author":"Zhang","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2013.03.010_bb0250","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ana.20751","article-title":"Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis","volume":"59","author":"Vandiedonck","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0255","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.nmd.2011.09.003","article-title":"PTPN22 and myasthenia gravis: replication in an Italian population and meta-analysis of literature data","volume":"22","author":"Provenzano","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.autrev.2013.03.010_bb0260","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/gene.2009.64","article-title":"The PTPN22gain-of-function+1858T(+) genotypes correlate with low IL-2 expression in thymomas and predispose to myasthenia gravis","volume":"10","author":"Chuang","year":"2009","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2013.03.010_bb0265","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nature06066","article-title":"An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus","volume":"448","author":"Giraud","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2013.03.010_bb0270","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1093\/hmg\/ddn246","article-title":"Autoimmune diseases: insights from genome-wide association studies","volume":"17","author":"Lettre","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2013.03.010_bb0275","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.4049\/jimmunol.179.6.3662","article-title":"Characterization of early stages of human B cell development by gene expression profiling","volume":"179","author":"Hystad","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0280","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00439-010-0908-2","article-title":"Conditional meta-analysis stratifying on detailed HLA genotypes identifies a novel type 1 diabetes locus around TCF19 in the MHC","volume":"129","author":"Cheung","year":"2011","journal-title":"Hum Genet"},{"key":"10.1016\/j.autrev.2013.03.010_bb0285","first-page":"265823","article-title":"Identification of TNIP1 polymorphisms by high resolution melting analysis with unlabelled probe: association with systemic lupus erythematosus","volume":"2012","author":"Zhang","year":"2012","journal-title":"Autoimmun Dis"},{"key":"10.1016\/j.autrev.2013.03.010_bb0290","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1136\/ard.2011.150102","article-title":"Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis","volume":"70","author":"Bowes","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2013.03.010_bb0295","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cytogfr.2012.04.002","article-title":"Emerging roles for TNIP1 in regulating post-receptor signaling","volume":"23","author":"Ramirez","year":"2012","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0300","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1084\/jem.20102177","article-title":"Polyubiquitin binding to ABIN1 is required to prevent autoimmunity","volume":"208","author":"Nanda","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.03.010_bb0305","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/WNL.0b013e318260cbd0","article-title":"A candidate gene for autoimmune myasthenia gravis","volume":"79","author":"Landoure","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.010_bb0310","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.autrev.2012.02.002","article-title":"Common mechanisms of autoimmune diseases (the autoimmune tautology)","volume":"11","author":"Anaya","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0315","doi-asserted-by":"crossref","first-page":"A377","DOI":"10.1016\/j.autrev.2011.11.001","article-title":"The role of gender and organ specific autoimmunity","volume":"11","author":"Nussinovitch","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0320","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1196\/annals.1405.019","article-title":"Regulatory and pathogenic mechanisms in human autoimmune myasthenia gravis","volume":"1132","author":"Le Panse","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.03.010_bb0325","doi-asserted-by":"crossref","first-page":"A479","DOI":"10.1016\/j.autrev.2011.11.022","article-title":"The influence of sex and gender on the immune response","volume":"11","author":"Oertelt-Prigione","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0330","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.4049\/jimmunol.175.8.5050","article-title":"Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis by promoting type 1-polarized immune responses","volume":"175","author":"Delpy","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0335","first-page":"115","article-title":"Localization of estrogen receptors and estrogen receptor-mRNA in female mouse thymus","volume":"20","author":"Kawashima","year":"1992","journal-title":"Thymus"},{"key":"10.1016\/j.autrev.2013.03.010_bb0340","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1210\/en.2004-1003","article-title":"Differential estrogen receptor expression in autoimmune myasthenia gravis","volume":"146","author":"Nancy","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.autrev.2013.03.010_bb0345","doi-asserted-by":"crossref","first-page":"A532","DOI":"10.1016\/j.autrev.2011.11.024","article-title":"The X chromosome and the sex ratio of autoimmunity","volume":"11","author":"Selmi","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0350","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1749-6632.1998.tb10961.x","article-title":"Drug-induced autoimmune myasthenia gravis","volume":"841","author":"Penn","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.03.010_bb0355","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2012.05.011","article-title":"Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine","volume":"250","author":"Poulas","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0360","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2008.12.008","article-title":"Interferon alpha and neuromuscular disorders","volume":"207","author":"Stubgen","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0365","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ana.23791","article-title":"Implication of dsRNA signaling in the etiology of autoimmune myasthenia gravis","volume":"73","author":"Cufi","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0370","article-title":"Infectome: a platform to trace infectious triggers of autoimmunity","author":"Bogdanos","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0375","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/j.1468-1331.2012.03773.x","article-title":"Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D3: a pilot study","volume":"19","author":"Askmark","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0380","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/WCO.0b013e3283533a7e","article-title":"Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics","volume":"25","author":"Simon","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0385","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.autrev.2012.07.007","article-title":"Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature","volume":"12","author":"Antico","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0390","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nri2527","article-title":"Antiviral immune responses: triggers of or triggered by autoimmunity?","volume":"9","author":"Munz","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0395","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2005.09.024","article-title":"Infections and autoimmune diseases","volume":"25 Suppl.","author":"Bach","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2013.03.010_bb0400","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.autrev.2011.11.008","article-title":"The viral enterprises in autoimmunity: conversion of target cells into de novo APCs is the presage to autoimmunity","volume":"11","author":"Temajo","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0405","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.20386","article-title":"Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG","volume":"57","author":"Leite","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0410","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/01.WNL.0000150587.71497.B6","article-title":"Thymus changes in anti-MuSK-positive and -negative myasthenia gravis","volume":"64","author":"Lauriola","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.010_bb0415","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/08916930903555935","article-title":"Thymoma and paraneoplastic myasthenia gravis","volume":"43","author":"Marx","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2013.03.010_bb0420","series-title":"International Histological Classification of Tumors","article-title":"Histological typing of tumors of the thymus","author":"Rosai","year":"1999"},{"key":"10.1016\/j.autrev.2013.03.010_bb0425","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jneuroim.2008.07.012","article-title":"Thymoma-associated myasthenia gravis: outcome, clinical and pathological correlations in 197 patients on a 20-year experience","volume":"201\u2013202","author":"Maggi","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0430","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1196\/annals.1405.018","article-title":"Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms","volume":"1132","author":"Strobel","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.03.010_bb0435","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1172\/JCI112069","article-title":"Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex","volume":"76","author":"Savino","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2013.03.010_bb0440","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2249.2007.03442.x","article-title":"Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas","volume":"149","author":"Scarpino","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0445","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mus.22103","article-title":"The thymus in myasthenia gravis: site of \u201cinnate autoimmunity\u201d?","volume":"44","author":"Cavalcante","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2013.03.010_bb0450","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.4049\/jimmunol.177.11.7868","article-title":"Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CCL21 in thymic hyperplasia","volume":"177","author":"Le Panse","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0455","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jneuroim.2008.06.028","article-title":"Thymus and myasthenia gravis: what can we learn from DNA microarrays?","volume":"201\u2013202","author":"Cizeron-Clairac","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0460","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4049\/jimmunol.167.4.1935","article-title":"Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis","volume":"167","author":"Sims","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0465","first-page":"137","article-title":"Acetylcholine receptor antibody synthesis in lymphocyte cultures","volume":"5","author":"McLachlan","year":"1981","journal-title":"J Clin Lab Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0470","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.410220205","article-title":"Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study","volume":"22","author":"Schluep","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0475","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jneuroim.2003.11.013","article-title":"Thymic myoid cells express high levels of muscle genes","volume":"148","author":"Mesnard-Rouiller","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0480","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.4049\/jimmunol.157.8.3752","article-title":"Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis","volume":"157","author":"Wakkach","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0485","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2353\/ajpath.2007.070240","article-title":"Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status","volume":"171","author":"Leite","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0490","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1172\/JCI113401","article-title":"Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients","volume":"81","author":"Melms","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2013.03.010_bb0495","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jneuroim.2008.06.027","article-title":"The myasthenia gravis thymus: a rare source of human autoantibody-secreting plasma cells for testing potential therapeutics","volume":"201\u2013202","author":"Hill","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0500","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1987.tb51282.x","article-title":"The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases","volume":"505","author":"Berrih-Aknin","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.03.010_bb0505","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00915728","article-title":"In vitro anti-acetylcholine receptor antibody synthesis by myasthenia gravis patient lymphocytes: correlations with thymic histology and thymic epithelial-cell interactions","volume":"7","author":"Safar","year":"1987","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0510","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1172\/JCI115843","article-title":"Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis","volume":"90","author":"Schonbeck","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2013.03.010_bb0515","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-510X(03)00087-X","article-title":"Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy (T-3b) in non-thymomatous myasthenia gravis patients: remission after 6years of follow-up","volume":"212","author":"Mantegazza","year":"2003","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2013.03.010_bb0520","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1212\/WNL.55.1.7","article-title":"Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"55","author":"Gronseth","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.010_bb0525","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/S0022-5223(03)00938-3","article-title":"The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer","volume":"126","author":"Okumura","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.autrev.2013.03.010_bb0530","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jtcvs.2006.10.026","article-title":"The distribution of parenchyma, follicles, and lymphocyte subsets in thymus of patients with myasthenia gravis, with special reference to remission after thymectomy","volume":"133","author":"Mori","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.autrev.2013.03.010_bb0535","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1182\/blood-2005-06-2383","article-title":"The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis","volume":"108","author":"M\u00e9raouna","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.03.010_bb0540","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.21628","article-title":"CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia","volume":"66","author":"Berrih-Aknin","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0545","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.4049\/jimmunol.174.9.5324","article-title":"Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis","volume":"174","author":"Feferman","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0550","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.imbio.2012.05.006","article-title":"SDF-1\/CXCL12 recruits B cells and antigen-presenting cells to the thymus of autoimmune myasthenia gravis patients","volume":"218","author":"Weiss","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.autrev.2013.03.010_bb0555","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2249.2003.02113.x","article-title":"Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and\/or myasthenia gravis","volume":"132","author":"Meager","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0560","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1196\/annals.1405.021","article-title":"Autoimmunizing mechanisms in thymoma and thymus","volume":"1132","author":"Willcox","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.03.010_bb0565","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/icb.2012.9","article-title":"The interferons and their receptors\u2014distribution and regulation","volume":"90","author":"de Weerd","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0570","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1084\/jem.181.2.547","article-title":"Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction","volume":"181","author":"Gu","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.03.010_bb0575","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1084\/jem.186.3.385","article-title":"Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice","volume":"186","author":"Balasa","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.03.010_bb0580","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.4049\/jimmunol.162.7.3775","article-title":"Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis","volume":"162","author":"Zhang","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0585","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.4049\/jimmunol.174.10.5941","article-title":"Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis","volume":"174","author":"Po\u00eba-Guyon","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0590","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/eji.200838913","article-title":"IFN-gamma-STAT1 signal regulates the differentiation of inducible Treg: potential role for ROS-mediated apoptosis","volume":"39","author":"Chang","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0595","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1210\/jc.2008-0935","article-title":"Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I","volume":"93","author":"Meloni","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2013.03.010_bb0600","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2567.2010.03280.x","article-title":"Interferon-alpha regulates the dynamic balance between human activated regulatory and effector T cells: implications for antiviral and autoimmune responses","volume":"131","author":"Golding","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2013.03.010_bb0605","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1074\/jbc.M608618200","article-title":"Viral infections activate types I and III interferon genes through a common mechanism","volume":"282","author":"Onoguchi","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2013.03.010_bb0610","doi-asserted-by":"crossref","first-page":"e1000017","DOI":"10.1371\/journal.ppat.1000017","article-title":"IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo","volume":"4","author":"Sommereyns","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.autrev.2013.03.010_bb0615","series-title":"Immunobiology: the Immune System in Health and Disease","first-page":"11","article-title":"Principals of innate and adaptive immunity","author":"Janeway","year":"2001"},{"key":"10.1016\/j.autrev.2013.03.010_bb0620","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/ni1004-971","article-title":"The interface between innate and adaptive immunity","volume":"5","author":"Hoebe","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0625","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/35100529","article-title":"Toll-like receptors and innate immunity","volume":"1","author":"Medzhitov","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0630","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0635","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.autrev.2007.11.006","article-title":"Toll-like receptors and autoimmunity","volume":"7","author":"Hurst","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0640","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.autrev.2008.07.028","article-title":"The role of innate immunity in the induction of autoimmunity","volume":"8","author":"Pisetsky","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0645","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/156652409787314453","article-title":"The role of Toll-like receptor pathways in the mechanism of type 1 diabetes","volume":"9","author":"Lien","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.autrev.2013.03.010_bb0650","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4331\/wjbc.v2.i7.167","article-title":"Toll-like receptors are potential therapeutic targets in rheumatoid arthritis","volume":"2","author":"Shotorbani","year":"2011","journal-title":"World J Biol Chem"},{"key":"10.1016\/j.autrev.2013.03.010_bb0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.08.010","article-title":"Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management","volume":"239","author":"Gambuzza","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0660","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1212\/WNL.0b013e31823ed057","article-title":"Association of innate immune activation with latent Epstein\u2013Barr virus in active MS lesions","volume":"78","author":"Tzartos","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.010_bb0665","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein\u2013Barr virus infection in the multiple sclerosis brain","volume":"204","author":"Serafini","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.03.010_bb0670","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1749-6632.2009.05123.x","article-title":"Innate pathways to B-cell activation and tolerance","volume":"1183","author":"Crampton","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.03.010_bb0675","doi-asserted-by":"crossref","first-page":"39789","DOI":"10.1074\/jbc.M112.383000","article-title":"Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands","volume":"287","author":"Green","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2013.03.010_bb0680","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.autrev.2007.11.027","article-title":"B cell autonomous TLR signaling and autoimmunity","volume":"7","author":"Meyer-Bahlburg","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.010_bb0685","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.smim.2011.01.016","article-title":"Toll-like receptor driven B cell activation in the induction of systemic autoimmunity","volume":"23","author":"Green","year":"2011","journal-title":"Semin Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0690","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1073\/pnas.1109173109","article-title":"A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells","volume":"109","author":"Miles","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2013.03.010_bb0695","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/eji.201041014","article-title":"Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs","author":"Hackl","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0700","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1172\/JCI29879","article-title":"Toll-like receptors and IFN-alpha: partners in autoimmunity","volume":"116","author":"Colonna","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2013.03.010_bb0705","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0065-2776(06)91004-9","article-title":"Endogenous TLR ligands and autoimmunity","volume":"91","author":"Wagner","year":"2006","journal-title":"Adv Immunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0710","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10753-012-9526-6","article-title":"Possible involvement of Toll-like receptors in the pathogenesis of myasthenia gravis","volume":"36","author":"Wang","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.autrev.2013.03.010_bb0715","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1371\/journal.ppat.0020062","article-title":"The thymus is a common target organ in infectious diseases","volume":"2","author":"Savino","year":"2006","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.autrev.2013.03.010_bb0720","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0002-9440(10)62960-4","article-title":"Increased toll-like receptor 4 expression in thymus of myasthenic patients with thymitis and thymic involution","volume":"167","author":"Bernasconi","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0725","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.2414848","article-title":"Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity","volume":"230","author":"Fujinami","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.autrev.2013.03.010_bb0730","article-title":"Myasthenia gravis following viral infection","volume":"20","author":"Korn","year":"1981","journal-title":"Eur Neurol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0735","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/mus.20746","article-title":"Anti-MuSK myasthenia gravis presenting with Epstein\u2013Barr virus-associated mononucleosis and immune-mediated diabetes mellitus","volume":"36","author":"Bhibhatbhan","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2013.03.010_bb0740","first-page":"1355","article-title":"Myasthenia gravis associated with dual infection of HIV and HTLV-I","volume":"18","author":"Verma","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2013.03.010_bb0745","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1172\/JCI114282","article-title":"Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus","volume":"84","author":"Schwimmbeck","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2013.03.010_bb0750","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJM198501243120407","article-title":"Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichia coli, Proteus vulgaris, and Klebsiella pneumoniae. Possible role in the pathogenesis of myasthenia gravis","volume":"312","author":"Stefansson","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2013.03.010_bb0755","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1212\/WNL.28.3.273","article-title":"Serum antibodies to cytomegalovirus in myasthenia gravis: effects of thymectomy and steroids","volume":"28","author":"Tindall","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.010_bb0760","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1212\/WNL.35.9.1381","article-title":"Antivirus antibodies in myasthenia gravis","volume":"35","author":"Klavinskis","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.010_bb0765","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1468-1331.2011.03636.x","article-title":"High anti-EBNA-1 IgG levels are associated with early-onset myasthenia gravis","volume":"19","author":"Csuka","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0770","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein\u2013Barr virus antibodies and risk of multiple sclerosis: a prospective study","volume":"286","author":"Ascherio","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2013.03.010_bb0775","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1212\/WNL.35.2.185","article-title":"Attempts to implicate viruses in myasthenia gravis","volume":"35","author":"Aoki","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.010_bb0780","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0165-5728(86)90082-2","article-title":"Attempted isolation of viruses from myasthenia gravis thymus","volume":"11","author":"Klavinskis","year":"1986","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0785","first-page":"385","article-title":"Epstein\u2013Barr virus genome in thymoma and thymic lymphoid hyperplasia","volume":"131","author":"McGuire","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0790","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1212\/WNL.0b013e3181d7d884","article-title":"Detection of poliovirus-infected macrophages in thymus of patients with myasthenia gravis","volume":"74","author":"Cavalcante","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.010_bb0795","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.21902","article-title":"Epstein\u2212Barr virus persistence and reactivation in myasthenia gravis thymus","volume":"67","author":"Cavalcante","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0800","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/978-1-4419-8216-2_7","article-title":"Epigenetic dysregulation of Epstein\u2013Barr virus latency and development of autoimmune disease","volume":"711","author":"Niller","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0805","first-page":"213092","article-title":"Inflammation and Epstein\u2013Barr virus infection are common features of myasthenia gravis thymus: possible roles in pathogenesis","volume":"2011","author":"Cavalcante","year":"2011","journal-title":"Autoimmun Dis"},{"key":"10.1016\/j.autrev.2013.03.010_bb0810","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1084\/jem.20081761","article-title":"Epstein\u2013Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3","volume":"206","author":"Iwakiri","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.03.010_bb0815","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2042-4280-2-1","article-title":"Innate immune modulation in EBV infection","volume":"2","author":"Ning","year":"2011","journal-title":"Herpesviridae"},{"key":"10.1016\/j.autrev.2013.03.010_bb0820","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ana.22488","article-title":"Intrathymic Epstein\u2013Barr virus infection is not a prominent feature of myasthenia gravis","volume":"70","author":"Kakalacheva","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0825","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ana.22522","article-title":"Lack of evidence for Epstein\u2013Barr virus infection in myasthenia gravis thymus","volume":"70","author":"Meyer","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.010_bb0830","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ana.22544","article-title":"Epstein\u2013Barr virus in myasthenia gravis thymus: a matter of debate","volume":"70","author":"Serafini","year":"2011","journal-title":"Ann Neurol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213000360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213000360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T19:17:57Z","timestamp":1715109477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997213000360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":166,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1568997213000360"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2013.03.010","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Etiology of myasthenia gravis: Innate immunity signature in pathological thymus","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2013.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}